These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7600788)

  • 1. Allergic contact dermatitis from a clonidine transdermal delivery system.
    Corazza M; Mantovani L; Virgili A; Strumia R
    Contact Dermatitis; 1995 Apr; 32(4):246. PubMed ID: 7600788
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.
    Polster AM; Warner MR; Camisa C
    Cutis; 1999 Mar; 63(3):154-5. PubMed ID: 10190065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral substitution in patients sensitized by transdermal clonidine treatment.
    Maibach HI
    Contact Dermatitis; 1987 Jan; 16(1):1-8. PubMed ID: 3816202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal clonidine application: long-term results in essential hypertension.
    Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
    Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic contact dermatitis from apraclonidine.
    Armisen M; Vidal C; Quintans R; Suarez A; Castroviejo M
    Contact Dermatitis; 1998 Oct; 39(4):193. PubMed ID: 9817226
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis from apraclonidine in eyedrops.
    Silvestre JF; Carnero L; Ramón R; Albares MP; Botella R
    Contact Dermatitis; 2001 Oct; 45(4):251. PubMed ID: 11683848
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing the contact dermatitis caused by a transdermal clonidine patch.
    McChesney JA
    West J Med; 1991 Jun; 154(6):736. PubMed ID: 1877221
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic contact dermatitis caused by rotigotine in a transdermal therapeutic system.
    Raison-Peyron N; Guillot B
    Contact Dermatitis; 2016 Aug; 75(2):121-2. PubMed ID: 27385523
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized allergic contact dermatitis from nitroglycerin in a transdermal therapeutic system.
    Pérez-Calderón R; Gonzalo-Garijo MA; Rodríguez-Nevado I
    Contact Dermatitis; 2002 May; 46(5):303. PubMed ID: 12084088
    [No Abstract]   [Full Text] [Related]  

  • 11. Contact dermatitis from estradiol in a transdermal therapeutic system.
    Panhans-Gross A; Gall H; Dziuk M; Peter RU
    Contact Dermatitis; 2000 Dec; 43(6):368-9. PubMed ID: 11140397
    [No Abstract]   [Full Text] [Related]  

  • 12. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis from nitroglycerin contained in 2 transdermal systems.
    Machet L; Martin L; Toledano C; Jan V; Lorette G; Vaillant L
    Dermatology; 1999; 198(1):106-7. PubMed ID: 10026420
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic contact dermatitis from estradiol and norethisterone acetate in a transdermal hormonal patch.
    Koch P
    Contact Dermatitis; 2001 Feb; 44(2):112-3. PubMed ID: 11205390
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic contact dermatitis caused by transdermal buprenorphine.
    Kyrklund C; Hyry H; Alanko K
    Contact Dermatitis; 2013 Jul; 69(1):60-1. PubMed ID: 23782362
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic contact dermatitis due to transdermal buprenorphine.
    Pérez-Pérez L; Cabanillas M; Loureiro M; Fernández-Redondo V; Labandeira J; Toribio J
    Contact Dermatitis; 2008 May; 58(5):310-2. PubMed ID: 18416765
    [No Abstract]   [Full Text] [Related]  

  • 17. Rebound hypertension associated with transdermal clonidine and contact dermatitis.
    White TM; Guidry JR
    West J Med; 1986 Jul; 145(1):104. PubMed ID: 3751022
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension by a new transdermal form of clonidine.
    Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
    J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.